About: Towards a cancer mission in Horizon Europe: recommendations

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Towards a cancer mission in Horizon Europe: recommendations Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Towards a cancer mission in Horizon Europe: recommendations
Creator	Solary, Eric Adami, Hans-Olov Aaronson, Neil Abou-Zeid, Nancy Apostolidis, Kathi Bardelli, Alberto Baumann, Michael Berns, Anton Bernards, Ren Brandberg, Yvonne Caldas, Carlos Calvo, Fabien Celis, J Celis, Julio Heitor, M Heitor, Manuel Ringborg, Ulrik Strang, Peter Tabernero, Josep Voest, Emile
topic	covid:3bd9224edce6e4604af45eeb6ad537760e1a743b#this
source	PMC
abstract	A comprehensive translational cancer research approach focused on personalized and precision medicine, and covering the entire cancer research–care–prevention continuum has the potential to achieve in 2030 a 10‐year cancer‐specific survival for 75% of patients diagnosed in European Union (EU) member states with a well‐developed healthcare system. Concerted actions across this continuum that spans from basic and preclinical research through clinical and prevention research to outcomes research, along with the establishment of interconnected high‐quality infrastructures for translational research, clinical and prevention trials and outcomes research, will ensure that science‐driven and social innovations benefit patients and individuals at risk across the EU. European infrastructures involving comprehensive cancer centres (CCCs) and CCC‐like entities will provide researchers with access to the required critical mass of patients, biological materials and technological resources and can bridge research with healthcare systems. Here, we prioritize research areas to ensure a balanced research portfolio and provide recommendations for achieving key targets. Meeting these targets will require harmonization of EU and national priorities and policies, improved research coordination at the national, regional and EU level and increasingly efficient and flexible funding mechanisms. Long‐term support by the EU and commitment of Member States to specialized schemes are also needed for the establishment and sustainability of trans‐border infrastructures and networks. In addition to effectively engaging policymakers, all relevant stakeholders within the entire continuum should consensually inform policy through evidence‐based advice.
has issue date	2020-08-04(xsd:dateTime)
bibo:doi	10.1002/1878-0261.12763
bibo:pmid	32749074
has license	cc-by
sha1sum (hex)	3bd9224edce6e4604af45eeb6ad537760e1a743b
schema:url	https://doi.org/10.1002/1878-0261.12763
resource representing a document's title	Towards a cancer mission in Horizon Europe: recommendations
has PubMed Central identifier	PMC7400777
has PubMed identifier	32749074
schema:publication	Mol Oncol
resource representing a document's body	covid:3bd9224edce6e4604af45eeb6ad537760e1a743b#body_text
is http://vocab.deri.ie/void#inDataset of	https://covidontheweb.inria.fr:4443/about/id/http/ns.inria.fr/covid19/3bd9224edce6e4604af45eeb6ad537760e1a743b
is schema:about of	named entity 'patients' named entity 'Meeting' named entity 'translational' named entity 'policies' named entity 'advice' named entity 'networks' named entity 'ensure' named entity 'specialized' named entity 'Meunier' named entity 'DRIVEN' named entity 'RESOURCES' named entity 'CANCER RESEARCH' named entity 'COVERING' named entity 'ADDITION' named entity 'TRANSLATIONAL RESEARCH' named entity 'ENTIRE' named entity 'AT RISK' named entity 'innovations' named entity 'policymakers' named entity 'harmonization' named entity 'comprehensive' named entity 'consensually' named entity 'European' named entity 'cancer' named entity 'patients' named entity 'survival' named entity 'Long-term support' named entity 'member' named entity 'research areas' named entity 'precision medicine' named entity 'high-quality' named entity 'outcomes research' named entity 'sustainability' named entity 'Long-term support' named entity 'translational research' named entity 'outcomes research' named entity 'balanced' named entity 'covering' named entity 'breast cancer screening' named entity 'patient-reported outcome' named entity 'translational research' named entity 'clinical research' named entity 'economic discrimination' named entity 'genomics' named entity 'prognosis' named entity 'epidemiology' named entity 'clinical trials' named entity 'Shared decision-making' named entity 'health care' named entity 'outcomes research' named entity 'European Commission' named entity 'observational studies' named entity 'immunotyping' named entity 'proof of principle' named entity 'OECI' named entity 'critical mass' named entity 'tertiary prevention' named entity 'palliative care' named entity 'multidisciplinary research' named entity 'clinical research'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software